BlackRock’s Ultragenyx Pharmaceutical RARE Stock Holding History

BlackRock’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$153M	Buy	7,299,598 +668,044	+10%	+$15M	﹤0.01%	1835
2025 Q4	$153M	Buy	6,631,554 +206,291	+3%	+$6.78M	﹤0.01%	1856
2025 Q3	$193M	Buy	6,425,263 +169,118	+3%	+$5.07M	﹤0.01%	1676
2025 Q2	$227M	Buy	6,256,145 +97,879	+2%	+$3.53M	﹤0.01%	1552
2025 Q1	$223M	Sell	6,158,266 -378,251	-6%	-$15.7M	﹤0.01%	1536
2024 Q4	$275M	Buy	6,536,517 +707,669	+12%	+$35.1M	0.01%	1475
2024 Q3	$324M	Buy	5,828,848 +225,496	+4%	+$11.5M	0.01%	1375
2024 Q2	$230M	Buy	5,603,352 +367,614	+7%	+$15.7M	0.01%	1521
2024 Q1	$244M	Sell	5,235,738 -2,662	-0.1%	-$126K	0.01%	1513
2023 Q4	$251M	Buy	5,238,400 +159,191	+3%	+$6.17M	0.01%	1503
2023 Q3	$181M	Buy	5,079,209 +12,182	+0.2%	+$483K	0.01%	1602
2023 Q2	$234M	Buy	5,067,027 +193,671	+4%	+$8.98M	0.01%	1478
2023 Q1	$195M	Buy	4,873,356 +536,513	+12%	+$23M	0.01%	1557
2022 Q4	$201M	Buy	4,336,843 +409,204	+10%	+$16.1M	0.01%	1527
2022 Q3	$163M	Buy	3,927,639 +330,055	+9%	+$17M	0.01%	1633
2022 Q2	$215M	Buy	3,597,584 +156,913	+5%	+$9.66M	0.01%	1475
2022 Q1	$250M	Sell	3,440,671 -43,981	-1%	-$3.06M	0.01%	1504
2021 Q4	$293M	Buy	3,484,652 +34,099	+1%	+$2.77M	0.01%	1453
2021 Q3	$311M	Sell	3,450,553 -41,388	-1%	-$3.74M	0.01%	1375
2021 Q2	$333M	Sell	3,491,941 -1,970,244	-36%	-$205M	0.01%	1382
2021 Q1	$622M	Buy	5,462,185 +174,709	+3%	+$23.8M	0.02%	828
2020 Q4	$732M	Buy	5,287,476 +478,279	+10%	+$56.7M	0.02%	665
2020 Q3	$395M	Sell	4,809,197 -101,469	-2%	-$8.41M	0.01%	887
2020 Q2	$384M	Buy	4,910,666 +347,135	+8%	+$23M	0.02%	878
2020 Q1	$203M	Sell	4,563,531 -169,553	-4%	-$8.8M	0.01%	1164
2019 Q4	$202M	Buy	4,733,084 +107,877	+2%	+$4.45M	0.01%	1481
2019 Q3	$198M	Buy	4,625,207 +208,992	+5%	+$11.4M	0.01%	1415
2019 Q2	$280M	Sell	4,416,215 -329,148	-7%	-$21M	0.01%	1178
2019 Q1	$329M	Buy	4,745,363 +268,551	+6%	+$15.3M	0.01%	1049
2018 Q4	$195M	Buy	4,476,812 +123,409	+3%	+$6.74M	0.01%	1334
2018 Q3	$332M	Sell	4,353,403 -35,947	-0.8%	-$2.92M	0.01%	1075
2018 Q2	$337M	Buy	4,389,350 +158,723	+4%	+$10.3M	0.02%	1027
2018 Q1	$216M	Buy	4,230,627 +498,740	+13%	+$25.1M	0.01%	1305
2017 Q4	$173M	Sell	3,731,887 -30,197	-0.8%	-$1.48M	0.01%	1491
2017 Q3	$200M	Buy	3,762,084 +264,493	+8%	+$15.7M	0.01%	1342
2017 Q2	$217M	Buy	3,497,591 +330,911	+10%	+$19.9M	0.01%	1238
2017 Q1	$215M	Buy	3,166,680 +3,163,586	+102,249%	+$241M	0.01%	1225
2016 Q4	$218K	Sell	3,094 -1,150	-27%	-$81.6K	﹤0.01%	2090
2016 Q3	$301K	Buy	4,244 +271	+7%	+$17.3K	﹤0.01%	1948
2016 Q2	$194K	Buy	3,973 +1,467	+59%	+$94.9K	﹤0.01%	2120
2016 Q1	$159K	Sell	2,506 -34,892	-93%	-$2.28M	﹤0.01%	1799
2015 Q4	$4.2M	Sell	37,398 -4,956	-12%	-$496K	0.01%	887
2015 Q3	$4.08M	Buy	42,354 +41,447	+4,570%	+$4.75M	0.01%	842
2015 Q2	$93K	Buy	907 +740	+443%	+$57.5K	﹤0.01%	1816
2015 Q1	$10K	Hold	167	–	–	﹤0.01%	2743
2014 Q4	$7K	Hold	167	–	–	﹤0.01%	2951
2014 Q3	$9K	Hold	167	–	–	﹤0.01%	2800
2014 Q2	$7K	Sell	167 -10,700	-98%	-$441K	﹤0.01%	3007
2014 Q1	$531K	Buy	+10,867	New	+$559K	﹤0.01%	1324

Other funds holding RARE

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return